Trial
NCT02038699
A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Jazz Pharmaceuticals
Collaborators
—
Condition
Advanced Glioblastoma
Intervention
ONC201
Why stopped
Protocol not activated.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-30